Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis

<div>CNV differences between subgroups. (a, b) Bar plot of fraction genome altered in the two identified subtypes of renal cancer in TCGA-KIRC cohort.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis 

Figure 5 | Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis 